44 results on '"Altamura, Concetta"'
Search Results
2. Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4–1BB: A preclinical study in multiple myeloma
3. Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study
4. Drug repurposing in skeletal muscle ion channelopathies
5. Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders
6. Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome
7. Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo
8. Editorial: Novel therapeutic approach in cancer: the role of ion channels and transporters
9. A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia
10. Skeletal muscle ClC-1 chloride channels in health and diseases
11. Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate
12. Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management.
13. Effects of Benzothiazolamines on Voltage-Gated Sodium Channels
14. A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions
15. A c.1775C?>?T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia
16. ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells
17. Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications
18. Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia
19. Anti-Angiogenic Activity of Drugs in Multiple Myeloma
20. Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review
21. Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes
22. Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels.
23. Effects of Benzothiazolamines on Voltage-Gated Sodium Channels
24. Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita
25. Target Mutation-Driven Drug Discovery
26. Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita
27. Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives
28. Targeted pharmacotherapy for trafficking defective ClC-1 mutations in myotonia congenita
29. Corrigendum: Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use‐Dependent Inhibitors of Voltage‐Gated Sodium Channels
30. Ion Channel Involvement in Tumor Drug Resistance
31. The Treatabolome Database and Platform: enhancing Rare Diseases’ treatment visibility
32. Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use‐Dependent Inhibitors of Voltage‐Gated Sodium Channels
33. Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy
34. Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine
35. Buprenorphine may be effective for treatment of paramyotonia congenita
36. Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
37. Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel
38. Synthesis and Evaluation of Voltage‐Gated Sodium Channel Blocking Pyrroline Derivatives Endowed with Both Antiarrhythmic and Antioxidant Activities
39. Pathomechanisms of a CLCN1 Mutation Found in a Russian Family Suffering From Becker's Myotonia
40. Synthesis and Evaluation of Voltage‐Gated Sodium Channel Blocking Pyrroline Derivatives Endowed with Both Antiarrhythmic and Antioxidant Activities.
41. The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel
42. Multidisciplinary study of a new CIC‐1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies
43. ClC-1 chloride channels: state-of-the-art research and future challenges
44. The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.